Qingrong Chen

National Institutes of Health — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

31h-index11.2kcitations188works5.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Hypoxia, and Metabolism(33), Sarcoma Diagnosis and Treatment(28), RNA modifications and cancer(27), Cancer-related gene regulation(26), Mitochondrial Function and Pathology(24)

Publications187 total

Oncopacket: integration of cancer research data using GA4GH phenopackets
Bioinformatics·2025Open Access
A simple liquid 3D cell culture paradigm models oxidative mitochondrial metabolism of epithelial breast cancer cells with relevance for lung metastases
2025Open Access
Modular and cloud-based bioinformatics pipelines for high-confidence biomarker detection in cancer immunotherapy clinical trials
PLoS ONE·2025Open Access
Proteogenomic characterization of invasive breast tumors in young women
npj Breast Cancer·2025· 3 citedOpen Access
The ESCRT protein CHMP5 promotes T cell leukemia by enabling BRD4-p300-dependent transcription
Nature Communications·2025· 2 citedOpen Access
TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells
Cancer Letters·2025· 6 cited
Nitric oxide inhibits ten-eleven translocation DNA demethylases to regulate 5mC and 5hmC across the genome
Nature Communications·2025· 9 citedOpen Access
Single Cell Transcriptome Analysis of CD34+ Cells from Patients with RUNX1-Fpdmm at Different Stages of Disease Progression
Blood·2024
Cellular fate of a plant virus immunotherapy candidate
Communications Biology·2024· 14 citedOpen Access
Phosphorylation by JNK switches BRD4 functions
Molecular Cell·2024· 15 citedOpen Access
Ten challenges and opportunities in computational immuno-oncology
Journal for ImmunoTherapy of Cancer·2024· 10 citedOpen Access
TRAIL-induced cytokine production via NFKB2 pathway promotes neutrophil chemotaxis and immune suppression in triple negative breast cancers
2024· 3 citedOpen Access
Analysis of cancer cell line and tissue RNA sequencing data reveals an essential and dark matrisome
Matrix Biology Plus·2024· 1 citedOpen Access
Evaluation of somatic copy number variation detection by NGS technologies and bioinformatics tools on a hyper-diploid cancer genome
Genome biology·2024· 29 citedOpen Access
Abstract PO3-13-10: Proteogenomic characterization of primary invasive breast tumors from young women compared to matched tumors from older women
Cancer Research·2024
Nitric oxide inhibits ten-eleven translocation DNA demethylases to regulate 5mC and 5hmC across the genome
2024· 3 citedOpen Access
Corrigendum: Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel
Frontiers in Oncology·2024· 1 citedOpen Access
The ESCRT protein CHMP5 promotes T cell leukemia by controlling BRD4-p300-dependent transcription
2024Open Access
Trail Induces Cytokine Production Via the Nfkb2 Pathway Promoting Neutrophil Chemotaxis and Neutrophil-Mediated Immune-Suppression in Triple Negative Breast Cancer Cells
SSRN Electronic Journal·2024Open Access
Abundant binary promoter switches in lineage-determining transcription factors indicate a digital component of cell fate determination
Cell Reports·2023· 3 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Javed Khan(22), Daoud Meerzaman(20), Jun S. Wei(17), Young Song(11), Cu Nguyen(9), Sven Bilke(8), Chunhua Yan(7), Dinah S. Singer(6), Adam Cheuk(5), Chand Khanna(5), Stephen M. Hewitt(5), Bin Zhu(5), Craig C. Whiteford(5), Anne Gégonne(4), Patricia Tsang(4), Joon‐Yong Chung(4), Daniel Catchpoole(4), Ying Hu(4), Peter A. Johansson(4), Ballachanda N. Devaiah(3)